Article Sidebar

PDF
Date Published: 20/04/2023
Abstract Views: 137
Views PDF: 117
DOI: https://doi.org/10.51298/vmj.v525i1B.5030
Issue
Vol. 525 No. 1B (2023)
Section
Các bài báo
How to Cite
Lê , T. D. ., Đỗ , T. C. ., & Thân , V. S. . (2023). EARLY RESULTS OF THE TRANSBRACIAL APPROACH EMBOLIZATON FOR TREATMENT OF OVER 8CM SYMPTOMATIC UTERINE FIBROMAS. Vietnam Medical Journal, 525(1B). https://doi.org/10.51298/vmj.v525i1B.5030

EARLY RESULTS OF THE TRANSBRACIAL APPROACH EMBOLIZATON FOR TREATMENT OF OVER 8CM SYMPTOMATIC UTERINE FIBROMAS

Thanh Dũng Lê 1,2,, Tiến Cảm Đỗ 3, Văn Sỹ Thân 1
1 Viet Duc hospital
2 VNU Hanoi-University of Medicine and Pharmacy
3 Hanoi medical university

Main Article Content

Abstract

Objectives: To evaluate the early results in treating over 8cm symptomatic uterine leiomyoma with transbrachial approach embolization after 3 months. Methods: The study involved 16 female patients (patients), with a mean age of 42.38 ± 8.7 years, having over 8cm symptomatic uterine leiomyoma and treated with transbrachial embolization. Clinical and magnetic resonance imaging features were collected before and three months after embolization. Results: All patients were successfully embolized with no procedure-related complications. After three months of embolization, the tumor diameter decreased by 12.42% (82.38mm compared with 94.06mm before treatment). 93.75% of patients stopped menorrhagia symptoms and significantly reduced abdominal pain after three months of embolization. The average tumor necrosis rate after treatment reached 68.6%, in which three patients with complete necrosis and one with necrosis <30% of the volume. Conclusion: Transbrachial embolization of the over 8cm uterine fibroma is safe and effective, helping to reduce the diameter of the tumor and improve early clinical symptoms after embolization.

Article Details

Keywords

large uterine leiomyoma, uterine leiomyoma nodule, brachial artery line

References

1. Glevin, K. and Palvio, P. Uterine Myomas in Pregnancy. Acta Obstet Gynecol Scand,69: p.617-19; 1990.
2. Dương Thị Cương và Nguyễn Đức Hinh. Phụ Khoa Dành Cho Thầy Thuốc Thực Hành,. nhà xuất bản y học, tr88-108; 1999.
3. Pavone D., Clemenza S., Sorbi F. and et al. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin obster gynaecol, 46, 3-11; 2018.
4. Llewellyn O, Patel NR, Mallon D, Quinn SD, Hamady M. Uterine Artery Embolisation for Women with Giant Versus Non-giant Uterine Fibroids: A Systematic Review and Meta-analysis. Cardiovasc Intervent Radiol. 2020;43(5):684-693. doi:10.1007/s00270-019-02359-7
5. Kitamura, Y., et al.,. Imaging Manifestations of Complication Associated with Uterine Artery Embolization. Radiographics,; 2005.
6. Phạm Gia Khánh. Nghiên Cứu Ứng Dụng và Phát Triển Kỹ Thuật Can Thiệp Nội Mạch Điều Trị Một Số Bệnh. Chương trình Khoa học và Công nghệ trọng điểm cấp nhà nước KCI; 2010.
7. Hiền NX. Nghiên Cứu Ứng Dụng Phương Pháp Nút Động Mạch Tử Cung Trong Điều Trị u Cơ Trơn Tử Cung. Luận văn tiến sỹ y học. Đại học y Hà Nội; 2011.
8. Zreik, T.G, et al.,. Cryomyolysis a New Procedure for the Conservative Treatment of Uterine Fibroids. J Am Assoc Gynecol Laparosc,; 1998.
9. Nassera, s . B. and Isaac, T. M. Myometrial Tumours. Current Obstetrics & Gynaccology, 14: p. 327-336.; 2004.
10. Lê Văn Khánh. Nghiên Cứu Kết Quả Ban Đầu Sử Dụng Hạt vi Cầu Embozene Trong Điều Trị u Có Trơn Tử Cung. Luận văn bác sĩ nội trú, Trường Đại học Y Hà Nội; 2016.